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Abstract
Filamentous basidiomycetes are difficult to identify in the clinical laboratory, mostly due to lack 
of sporulation, and their role as agents of fungal infection can be difficult to assess. More cases of 
infection with these agents are being reported as more laboratories gain proficiency with the 
recognition of their subtle morphologic features and the use of DNA-based methods for 
identification. Most infections occur in the respiratory tract and sinuses, although brain infection 
has been reported. Susceptibility testing suggests that these agents will respond well to azole drugs 
other than fluconazole.
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Introduction
The identification and assessment of filamentous basidiomycete fungi from clinical 
specimens has long been difficult. First, many of these isolates are sterile in the clinical 
laboratory. Their lack of sporulation renders them difficult to identify without molecular-
based testing. Second, their pathogenicity is difficult to assess either because many of these 
species were recovered from non-sterile body sites or because the species involved are not 
routinely considered human pathogens.
A number of basidiomycete fungi have been reported recently as agents of human infection 
or as agents of hypersensitivity and allergic reactions. This paper is intended as a review of 
case reports and a discussion of the role of these agents in human disease. This review will 
not cover basid-iomycete yeasts such as Cryptococcus species.
Basidiomycete is a commonly used informal term for all members of the phylum 
Basidiomycota. They are further subdivided taxonomically into three subphyla, 16 classes, 
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and 52 orders, and include organisms as diverse as mushrooms, stinkhorns and barberry-
wheat rusts [1]. Basidiomycota reproduce sexually through the production of specialized 
club-shaped cells called basidia, in which basidiospores are produced through meiosis. 
There are many variations in their life cycles. Some basidiomycetes also reproduce 
asexually. In the clinical laboratory, most basidiomycete fungi are fast-growing, cottony to 
fluffy colonies, hyaline to slightly brownish in color, and may produce crystals [2]. Some 
genera also produce arthroconidia, which causes them to be mistaken for the thermally 
dimorphic ascomycete fungus Coccidioides. Most basid-iomycetes are tolerant to benomyl 
(2–10 μg/ml) and sensitive to cycloheximide, allowing them to be distinguished from 
Coccidioides, which is resistant to cycloheximide. Many basidiomycetes are sterile and will 
not sporulate in the laboratory, although some colonies may display clamp connections 
and/or fruiting bodies such as basidiocarps (mushrooms). A clamp connection is a hyphal 
structure allowing a connection between two cells, allowing transfer of daughter nuclei, and 
resulting in a dikaryon, or a cell with two distinct haploid nuclei.
Some basidiomycete fungi have been implicated in hypersensitivity syndromes such as 
fungus-associated chronic cough [3]. Ogawa et al. studied 17 patients with fungus-
associated chronic cough. When challenged with an antigenic solution from the 
basidiomycete Bjerkandera adusta, 11 of these patients showed a positive response. They 
concluded that B. adusta may play a role in enhancing the cough severity of patients who are 
sensitized to this fungus. Another fungus, Sporotrichum pruinosum, was recovered in 
repeated culture of the respiratory tract of three patients with cough, dyspnea, and sputum 
production. Two of these patients also demonstrated hypersensitivity to S. pruinosum when 
challenged in a skin test. The authors concluded that this basidiomycete fungus could 
display pathogenic potential [4].
Probably the most notorious human pathogen in this group is Schizophyllum commune, 
which was first reported as a human pathogen many decades ago in a nail infection [5]. This 
hyaline fungus is widely distributed in the environment and can be found in decaying 
organic matter such as rotten wood. In the laboratory, it may produce basidiocarps 
containing basidiospores, and thus can be identified by recognition of these structures. 
However, many isolates do not produce these structures and manifest as hyaline 
nonsporulating molds. The types of infection caused by this fungus can range from asthma 
to brain lesion, and can occur in both immunocompetent and immunocompromised patients. 
In their 2013 paper, Chowdhary et al. reviewed the existing literature and found 71 reported 
cases of S. commune infection [6••]. Most cases [22] were sinusitis, followed by allergic 
bronchopulmonary disease [20], fungus ball [2], and asthma [2]. Only four cases were 
extrapulmonary, and were one case each of onychomycosis, brain abscess, meningitis, and 
palate ulceration. Most cases [33] were reported from Japan, followed by Iran [7], and 
United States [6••]. The authors ascribed the predominance of cases in Japan to greater 
awareness of the disease and the agent, although climate and weather factors may also be 
involved.
Ogawa et al. reported two patients who both demonstrated bronchial asthma due to S. 
commune [7]. In both cases, their elevated levels of specific S. commune IgG decreased 
during a course of antifungal therapy. A case of bronchopneumonia due to S. commune was 
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reported in a patient immunocompromised due to gastric carcinoma [8]. This patient was 
cured after 6 weeks of intravenous fluconazole. In their recent report, Chowdhary et al. 
reviewed 143 cases of allergic bronchopulmonary mycosis and found that S. commune was 
reported in 11 % of cases, mostly from Japan [9].
S. commune has also been reported as an agent of sinusitis. In one unusual case from Japan, 
a recipient of a cord blood transfusion for treatment of leukemia developed sinusitis 13 days 
after the transplant. This patient was successfully treated with 2 months of liposomal 
amphotericin followed by oral voriconazole [10]. Allergic fungal sinusitis caused by S. 
commune was reported in a young Korean girl who presented with nasal obstruction and 
purulent discharge. S. commune was recovered from culture of allergic mucin recovered at 
endoscopic surgery [11]. In another case from Korea, this organism was the causative agent 
of a sino-orbital infection diagnosed in an immunocompetent patient who presented with 
sinusitis and an orbital tumor [12]. Ethmoido-maxillary sinusitis caused by S. commune was 
also reported in an immunocompetent patient in France. The patient recovered well after 
sinus surgery and did not require antifungal treatment [13].
This organism can produce deeper respiratory infection. Two cases were reported from 
India, one of allergic-bronchopulmonary disease in a patient taking inhaled steroids, and one 
case of pulmonary fungus ball in a patient with a previous history of tuberculosis [6••]. 
Schizophyllum commune has also been reported as an agent of eye infections. A case of 
keratitis was reported from India [14], where the fungus was recovered in culture of corneal 
scrapings. Topical voriconazole and intraocular amphotericin B as well as surgery were 
required to treat the infection in this case.
The most serious manifestation of fungal infection with S. commune is brain abscess. Two 
cases have been reported in the literature. The first was reported in 1996, as a pulmonary 
infection that migrated to the brain [15]. The patient was originally misdiagnosed with 
lymphoma and steroid therapy was initiated. At presentation, culture of multiple bilateral 
lung masses revealed a white nonsporulating mold that was thought to be Aspergillus 
species. A magnetic resonance image (MRI) of the brain showed a right frontal lobe lesion, 
from which fungal elements thought to be Aspergillus were detected. The patient received 
amphotericin B, itraconazole, and fluconazole before expiring of respiratory failure and 
sepsis due to bacterial pneumonia. A white mold later identified as S. commune was 
recovered from lung and brain tissue at autopsy. The second case was reported from Austria 
[16]. A patient with diabetes presented with severe headache, and MRI revealed three 
abscesses in the right frontal brain and bilateral sinusitis. Sinus surgery was performed and 
fungal elements were detected. Culture of brain abscess drainage grew S. commune. 
Liposomal amphotericin was administered for 5 weeks, and the patient was discharged with 
oral posaconazole.
Another basidiomycete organism reported as an agent of human infection is 
Hormographiella aspergillata, the anamorph of Coprinopsis cinerea (formerly called 
Coprinus cinereus). This organism was reported in three invasive infections in leukemia 
patients [17]. All patients had pulmonary infiltrates, and one patient also had cerebral and 
ocular disease. All of these patients died despite antifungal therapy. A French group also 
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reported H. aspergillata infection in two neutropenic patients who developed pulmonary 
infections with this organism while receiving empiric caspofungin therapy for fungal 
pneumonia [18]. One patient died, but the other recovered after therapy was changed to 
liposomal amphotericin B. Further investigation showed that 19 breakthrough fungal 
infections had occurred in three French university hospitals while patients were receiving 
caspofungin [19••]. One of these infections was caused by Hormographiella. In these 
patients, caspofungin had been prescribed either as prophylaxis or therapy for various fungal 
infections. In a further case, a patient who had undergone allogeneic bone marrow transplant 
for treatment of leukemia developed a lesion on the right forearm. The lesion was 
empirically treated with caspofungin, and the lesion when biopsied 12 days later showed 
fungal elements. H. aspergillata was recovered in culture. Although the patient ultimately 
underwent surgical resection of the lesion and received treatment with amphotericin and 
voriconazole, she had persistent fever and ultimately expired from respiratory failure and 
septic shock [20]. In this case, the patient appeared to have developed the lesion prior to the 
administration of caspofungin, although the drug was used for empiric therapy. These case 
reports should serve as a caution to clinicians about the unintended consequences of 
administering echinocandin drugs to high-risk patients.
Several other basidiomycete genera have been reported as agents of infection. In a report 
from India, the wood rot organism Ceriporia lacerata was recovered from respiratory 
samples in four patients with preexisting lung damage caused by tuberculosis or chronic 
obstructive pulmonary disease [21]. In one case the fungus appeared as a commensal and 
probably did not cause disease. In the other three cases, the fungus was probably the agent 
of bronchopneumonia. Two patients received itraconazole, but the outcome could not be 
assessed because patients were lost to follow-up. A case of soft tissue infection was reported 
to be caused by the basidiomycete fungus Phellinus undulatus [22]. The organism was 
identified using DNA sequencing, as it did not produce any diagnostic features in culture. 
Another wood-decaying fungus, Irpex lacteus, was recovered from a pulmonary abscess in 
an immunosuppressed child [23]. The basidiomycete Inonotus (Phellinus) tropicalis was 
recovered from multiple specimens, including a bone marrow aspirate and paraspinal 
abscess tissue, in a patient with chronic granulomatous disease [24]. A case of pulmonary 
fungus ball due to Perenniporia species was reported from India, in a diabetic patient with a 
history of tuberculosis [25]. The patient was not treated with antifungals. Finally, a patient 
from India who was receiving an umbilical cord blood transplant for Hodgkin's lymphoma 
developed pulmonary and brain infection [26]. A white mold was recovered from bronchial 
washing and brain biopsy samples. The mold was identified as Volvariella volvacea, a 
paddy straw mushroom, commonly found in tropical regions of the world, including China 
and India. Despite aggressive treatment, the patient expired. It was assumed that the patient 
had been exposed to the fungus sometime earlier in India, and her profound 
immunosuppression permitted the fungus to begin replicating actively. All of these cases 
demonstrate that filamentous basidiomycetes can be agents of infection in compromised 
hosts. Patients can be compromised by immunosuppression or by physical changes to the 
lung, such as in damage caused by prior tuberculosis lesions.
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Filamentous basidiomycetes are difficult to identify in the routine clinical laboratory. They 
usually present as white, orange, golden, or tan, floccose to wooly colonies [2, 27]. They 
grow rapidly at 25 °C and 37 °C, filling the plate in 2– 3 days. Some genera will grow at 
higher temperatures including 40–42 °C. Basidiomycetes are tolerant to benomyl [28], and 
sensitive to cycloheximide, although Sutton et al. report one Inonotus strain that grew in the 
presence of 0.04 % cycloheximide [24]. Because so many basidiomycetes are recovered 
from respiratory samples, one important requirement is to distinguish basidiomycetes from 
dimorphic fungi such as Coccidioides, Histoplasma and Blastomyces, which have similar 
colonial morphology. This can be determined because dimorphic pathogens usually grow in 
the presence of cycloheximide, and usually fail to produce a mold phase at 37 °C. A 
nonsporulating hyaline mold that grows at 37 °C, fails to grow on cycloheximide, and grows 
on benomyl agar can be suspected to be a basidiomycete. It is important to appreciate that 
many such isolates have been presumptively identified as Aspergillus species or other 
molds, and this may not be the case.
Some basidiomycetes will produce morphologic characteristics that provide clues to their 
taxonomic origin. Many strains of Schizophyllum commune produce a distinctive bleach-like 
smell. Some isolates produce crystals, which can be seen on the culture plate. Some isolates 
will produce clamp connections or spicules on the hyphae, which can be seen 
microscopically, and some isolates may produce basidiocarps (mushrooms) after exposure 
of the culture plate to alternating cycles of light and darkness (culture slant can be left on the 
bench for several weeks). In a recent study Chowdhary et al. reported that only four of 26 
isolates of S. commune produced basidiocarps after 4–5 weeks at 28 °C with exposure to 
periodic light [6••]. Some isolates (particularly Bjerkandera adusta) produce arthroconidia, 
which require attention to distinguish them from Coccidioides arthroconidia, usually by 
assessing growth on cycloheximide as described above. However, most isolates do not 
sporulate or produce any diagnostic structures allowing an identification to be made 
morphologically.
DNA-based methods are particularly helpful in confirming the identification of 
basidiomycete fungi. Usually the ribosomal ITS (intervening transcribed spacer) region is 
used for this purpose [29]. Pounder et al. sequenced the ITS region from 50 isolates of 
nonsporulating molds received in their reference laboratory, and identified five isolates of 
Schizophyllum commune, one isolate of Coprinus sp., and 32 isolates of other filamentous 
basidiomycetes using a 93 % identity cutoff for identification to the genus level [30]. A 
cautionary note was raised in a later analysis of ribosomal sequences [31••]. In this study, 
comparison of the BLAST results in the GenBank database for 168 ITS and ribosomal large 
subunit D1-D2 region sequences showed that the same species identification was 
demonstrated by both regions with only 48 isolates (28 %). At the genus level, only 82 
isolates (48 %) showed the same genus identification using both regions. In 119 cases, 
(70.8%) the authors were unable to assign a conclusive identification at the species level. In 
many cases, either a corresponding ITS region or a D1-D2 region deposit in GenBank was 
lacking. Only 8 % of the isolates in this study had a complete ITS region deposit and only 10 
% had a complete D1D2 deposit. Thirty percent of the species that were identified had either 
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an ITS or a D1D2 sequence that matched a deposit in GenBank, but not both. Other 
problems associated with the GenBank database, such as the continued appearance of 
incorrect or obsolete nomenclature, have been noted by others [32, 33].
Antifungal Susceptibility
The antifungal susceptibility profiles of basidiomycete fungi have been determined by 
several investigators. It should be appreciated that there is no standardized method for 
testing filamentous basidiomycetes, and no interpretive breakpoints exist. However, 
determination of minimum inhibitory concentration (MIC) values can provide some estimate 
of that drug's success in treatment, particularly if the MIC is very high. In an early study, 44 
clinical isolates of basidiomycete fungi were tested using a modification of the macrobroth 
dilution method CLSI M-38P [34]. They found that the geometric mean (GM) for 
amphotericin, itraconazole, voriconazole, and posaconazole were consistently low, and the 
values for fluconazole and flucytosine were somewhat higher. Chowdhary et al. tested 30 
isolates of Schizophyllum commune using a modified version of the CLSI M-38A2 
microbroth dilution method [35••]. These isolates had a low geometric mean (GM) for 
amphotericin (0.29 μg/ml) and several azoles (itraconazole 0.2 μg/ml; voriconazole 0.24 μg/
ml), but a high GM for fluconazole (19.39 μg/ml) and flucytosine (17.28 μg/ml). They also 
describe cases of invasive pulmonary infection and fungus ball that were successfully 
treated with voriconazole and/or itraconazole. In contrast, in some individual case reports, 
high MICs to itraconazole have been reported along with treatment failure [36]. It appears 
that, in general, amphotericin and azoles other than fluconazole may be useful for treatment 
of basidiomycete infections. It is not clear if different fungal genera show differing 
susceptibility to antifungal agents.
Conclusions
Filamentous basidiomycetes are common environmental organisms, and some genera have 
demonstrated pathogenic potential in humans. These organisms are usually agents of 
respiratory and sinus infections, reflecting inhalation as a portal of entry, and can cause 
infections in both immunocompetent and immunosuppressed hosts [37]. Basidiomycetes can 
also be recovered from respiratory sources without signs of infection, suggesting that these 
agents can also colonize the respiratory tree. Recent studies have suggested a link between 
use of caspofungin drugs and acquisition of basidiomycetes as agents of secondary infection 
in highly immunosuppressed hosts. These isolates are difficult to identify in the clinical 
laboratory because they usually present as hyaline nonsporulating molds with no specific 
diagnostic features. They can be confused with other hyaline molds, especially Aspergillus 
species. DNA sequencing tools are usually required in identifying these organisms, but 
public DNA databases may not contain comprehensive basidiomycete sequences. Treatment 
can be successful when azole agents other than fluconazole are used, with or without 
amphotericin B.
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